Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.

Articles in this section

  • Updated Hepatitis C Treatment Guidelines

  • Genotypes Fact Sheet

  • Viekira XR and Technivie Fact Sheet

    Viekira XR is a combination of hepatitis C virus–fighting drugs (paritaprevir/ritonavir/ombitasvir and dasabuvir) that block different steps of the virus life cycle. In the United States, Viekira XR is approved for people with hepatitis C genotype 1 who are over 18 years old. Viekira XR was (...) More

  • Epclusa Fact Sheet

    Epclusa is a fixed-dose combination of two HCV-fighting drugs (sofosbuvir and velpatasvir) in one pill. In the United States, Epclusa is approved for people with all hepatitis C genotypes (1–6) who are 18 years of age and older. The fact sheet provides information about this treatment (...) More